Skip to main content
Caplight Logo









Guangzhou Yinming Biomedical Technology

Guangzhou Yinming Biomedical Technology

Private
GuangzhouHealthcare & Life Scienceshttps://ming-med.com/

Last Round

Private Equity

Jul 8, 2022

Est. Valuation

$616M

Total Funding Raised

$129.4M

Company Overview

Guangzhou Yinming Biomedical Technology is a biotechnology company that develops pharmaceutical drugs, including ophthalmic medications, recombinant botulinum toxins, immuno-oncology therapies, and veterinary immune drugs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medical devicesdiagnostic equipmentPOCTpoint-of-care testinghematology analyzerclinical chemistry analyzerlaboratory information management systemLIMSdiagnostic reagentsclinical laboratoryrazor-and-blade modelmedical diagnosticslab automationbiomedical technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Yinming Biomedical Technology Comparables

Compare Guangzhou Yinming Biomedical Technology with similar companies based on industry and business-model similarity.

Guangzhou Yinming Biomedical Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fosun Pharma
75%
Arctic Vision
46%
VivaVision Biotech
37%

Guangzhou Yinming Biomedical Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 8, 2022
Series A ExtensionSep 13, 2021
Series AMar 17, 2021

Guangzhou Yinming Biomedical Technology Investors

Notable investors and investment history

Guangzhou Yinming Biomedical Technology investors
InvestorRounds
Fosun RZ CapitalSeries A Extension
JCP CapitalSeries A
Oceanpine CapitalSeries A Extension
Huajin CapitalSeries A, Series A Extension
Lightspeed China PartnersSeries A
Tiger Jade CapitalSeries A Extension
Flower City VenturesSeries A, Series A Extension

Guangzhou Yinming Biomedical Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou Yinming Biomedical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Yinming Biomedical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Employee Range4
Year Founded2019
Last FundingJul 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.